Mannkind (MNKD) Free Cash Flow (2010 - 2026)
Mannkind (MNKD) reported Free Cash Flow of -$5.6 million for Q1 2026, up 16.03% year-over-year from -$4.9 million in Q1 2025, and up 27.35% on a QoQ basis from -$7.8 million in Q4 2025.
Mannkind (MNKD) has 17 years of Free Cash Flow data on file, last reported at -$5.6 million in Q1 2026.
- Quarterly Free Cash Flow rose 16.03% year-over-year to -$5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (down 11.22% YoY) and the FY2025 annual result came in at $17.6 million, down 46.26% from the prior year.
- Free Cash Flow grew to -$5.6 million in Q1 2026 per MNKD's latest filing, from -$7.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $31.4 million in Q3 2023 and bottomed at -$29.1 million in Q2 2022.
- The 5-year median for Free Cash Flow is -$1.3 million (2023), against an average of -$649588.2.
- Peak annual rise in Free Cash Flow reached 6427.5% in 2025, while the deepest fall reached 233.18% in 2025.
- Tracing MNKD's Free Cash Flow over 5 years: stood at -$8.5 million in 2022, then soared by 363.44% to $22.5 million in 2023, then tumbled by 35.77% to $14.4 million in 2024, then sank by 153.7% to -$7.8 million in 2025, then climbed by 27.35% to -$5.6 million in 2026.
- Per Business Quant, the three latest MNKD Free Cash Flow figures stand at -$5.6 million (Q1 2026), -$7.8 million (Q4 2025), and $24.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -5.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.63 Mn |
| Mar 31, 2026 | -5.63 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Sep 30, 2025 | 24.26 Mn |
| Sep 30, 2025 | 24.26 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Dec 31, 2024 | 14.44 Mn |
| Dec 31, 2024 | 14.44 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Jun 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 5.04 Mn |
| Mar 31, 2024 | 5.04 Mn |
| Dec 31, 2023 | 22.48 Mn |
| Dec 31, 2023 | 22.48 Mn |
| Sep 30, 2023 | 31.35 Mn |
| Sep 30, 2023 | 31.35 Mn |
| Jun 30, 2023 | -20.15 Mn |
| Jun 30, 2023 | -20.15 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | -8.53 Mn |
| Dec 31, 2022 | -8.53 Mn |
| Sep 30, 2022 | -27.28 Mn |
| Sep 30, 2022 | -27.28 Mn |
| Jun 30, 2022 | -29.15 Mn |
| Jun 30, 2022 | -29.15 Mn |
| Mar 31, 2022 | -23.30 Mn |
| Mar 31, 2022 | -23.30 Mn |
| Dec 31, 2021 | -7.34 Mn |
| Dec 31, 2021 | -7.34 Mn |
| Sep 30, 2021 | -20.28 Mn |
| Sep 30, 2021 | -20.28 Mn |
| Jun 30, 2021 | -21.65 Mn |
| Jun 30, 2021 | -21.65 Mn |
| Mar 31, 2021 | -13.71 Mn |
| Mar 31, 2021 | -13.71 Mn |
| Dec 31, 2020 | -262,000.00 |
| Dec 31, 2020 | -262,000.00 |
| Sep 30, 2020 | -13.46 Mn |
| Sep 30, 2020 | -13.46 Mn |
| Jun 30, 2020 | -3.95 Mn |
| Jun 30, 2020 | -3.95 Mn |
| Mar 31, 2020 | -11.25 Mn |
| Mar 31, 2020 | -11.25 Mn |
| Dec 31, 2019 | -7.47 Mn |
| Dec 31, 2019 | -7.47 Mn |
| Sep 30, 2019 | -51.46 Mn |
| Sep 30, 2019 | -51.46 Mn |
| Jun 30, 2019 | -20.25 Mn |
| Jun 30, 2019 | -20.25 Mn |
| Mar 31, 2019 | -11.87 Mn |
| Mar 31, 2019 | -11.87 Mn |
| Dec 31, 2018 | 24.99 Mn |
| Dec 31, 2018 | 24.99 Mn |
| Sep 30, 2018 | -13.92 Mn |
| Sep 30, 2018 | -13.92 Mn |
| Jun 30, 2018 | -27.15 Mn |
| Jun 30, 2018 | -27.15 Mn |
| Mar 31, 2018 | -21.65 Mn |
| Mar 31, 2018 | -21.65 Mn |
| Dec 31, 2017 | -29.98 Mn |
| Dec 31, 2017 | -29.98 Mn |
| Sep 30, 2017 | -23.27 Mn |
| Sep 30, 2017 | -23.27 Mn |
| Jun 30, 2017 | -20.03 Mn |
| Jun 30, 2017 | -20.03 Mn |
| Mar 31, 2017 | 8.51 Mn |
| Mar 31, 2017 | 8.51 Mn |
| Dec 31, 2016 | -12.75 Mn |
| Dec 31, 2016 | -12.75 Mn |
| Sep 30, 2016 | -23.07 Mn |
| Sep 30, 2016 | -23.07 Mn |
| Jun 30, 2016 | -11.51 Mn |
| Jun 30, 2016 | -11.51 Mn |
| Mar 31, 2016 | -31.90 Mn |
| Mar 31, 2016 | -31.90 Mn |
| Dec 31, 2015 | -22.87 Mn |
| Dec 31, 2015 | -22.87 Mn |
| Sep 30, 2015 | -21.12 Mn |
| Sep 30, 2015 | -21.12 Mn |
| Jun 30, 2015 | -22.34 Mn |
| Jun 30, 2015 | -22.34 Mn |
| Mar 31, 2015 | -1.18 Mn |
| Mar 31, 2015 | -1.18 Mn |
| Dec 31, 2014 | -40.71 Mn |
| Dec 31, 2014 | -40.71 Mn |
| Sep 30, 2014 | 90.77 Mn |
| Sep 30, 2014 | 90.77 Mn |
| Jun 30, 2014 | -31.68 Mn |
| Jun 30, 2014 | -31.68 Mn |
| Mar 31, 2014 | -38.40 Mn |
| Mar 31, 2014 | -38.40 Mn |
| Dec 31, 2013 | -40.22 Mn |
| Dec 31, 2013 | -40.22 Mn |
| Sep 30, 2013 | -33.14 Mn |
| Sep 30, 2013 | -33.14 Mn |
| Jun 30, 2013 | -29.88 Mn |
| Jun 30, 2013 | -29.88 Mn |
| Mar 31, 2013 | -33.49 Mn |
| Mar 31, 2013 | -33.49 Mn |
| Dec 31, 2012 | -28.16 Mn |
| Dec 31, 2012 | -28.16 Mn |
| Sep 30, 2012 | -34.38 Mn |
| Sep 30, 2012 | -34.38 Mn |
| Jun 30, 2012 | -25.14 Mn |
| Jun 30, 2012 | -25.14 Mn |
| Mar 31, 2012 | -32.81 Mn |
| Mar 31, 2012 | -32.81 Mn |
| Dec 31, 2011 | -20.51 Mn |
| Dec 31, 2011 | -20.51 Mn |
| Sep 30, 2011 | -36.63 Mn |
| Sep 30, 2011 | -36.63 Mn |
| Jun 30, 2011 | -40.86 Mn |
| Jun 30, 2011 | -40.86 Mn |
| Mar 31, 2011 | -32.70 Mn |
| Mar 31, 2011 | -32.70 Mn |
| Dec 31, 2010 | -42.91 Mn |
| Dec 31, 2010 | -42.91 Mn |
| Sep 30, 2010 | -36.40 Mn |
| Sep 30, 2010 | -36.40 Mn |